These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 27611107)
1. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer. Yang Q; Cao X; Tao G; Zhou F; Zhao P; Shen Y; Chen X Cell Biol Int; 2017 Jan; 41(1):79-83. PubMed ID: 27611107 [TBL] [Abstract][Full Text] [Related]
2. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo. He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214 [TBL] [Abstract][Full Text] [Related]
3. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Da C; Liu Y; Zhan Y; Liu K; Wang R Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176 [TBL] [Abstract][Full Text] [Related]
4. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. Kong FF; Zhu YL; Yuan HH; Wang JY; Zhao M; Gong XD; Liu F; Zhang WY; Wang CR; Jiang B Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137. Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958 [TBL] [Abstract][Full Text] [Related]
6. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158 [TBL] [Abstract][Full Text] [Related]
7. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells. Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910 [TBL] [Abstract][Full Text] [Related]
8. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer. Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699 [TBL] [Abstract][Full Text] [Related]
9. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597 [TBL] [Abstract][Full Text] [Related]
10. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer. Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
12. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157 [TBL] [Abstract][Full Text] [Related]
13. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6. Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634 [TBL] [Abstract][Full Text] [Related]
14. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC. Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786 [TBL] [Abstract][Full Text] [Related]
15. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells. Wang H; Zhang Y; Wu Q; Wang YB; Wang W Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1-induced epithelial to mesenchymal transition increases mitochondrial content in the A549 non-small cell lung cancer cell line. Xu Y; Lu S Mol Med Rep; 2015 Jan; 11(1):417-21. PubMed ID: 25323156 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. Maitah MY; Ali S; Ahmad A; Gadgeel S; Sarkar FH PLoS One; 2011 Jan; 6(1):e16068. PubMed ID: 21249152 [TBL] [Abstract][Full Text] [Related]
18. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells. Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245 [TBL] [Abstract][Full Text] [Related]
19. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer. Yao Y; Shi M; Liu S; Li Y; Guo K; Ci Y; Liu W; Li Y Mol Carcinog; 2016 Nov; 55(11):1714-1727. PubMed ID: 26509557 [TBL] [Abstract][Full Text] [Related]
20. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]